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Background: Chromolaena odorata L. leaf was reported to contain phenolic 
group compounds, such as flavonoids. Flavonoid compounds have been re-
ported to have antioxidant activity. Based on in vitro study, Chromolaena odo-
rata L. leaves have potent antioxidant activity. However, in vivo, studies with 
dose variations have not been reported.  
Purpose: This study evaluates the antioxidant activity with various doses of eth-
anolic extract of Chromolaena odorata L. leaves against male Wistar rats in-
duced by paracetamol. 
Methods: Flavonoid contents were measured spectrophotometrically based on 
the formation of a complex flavonoid-aluminum. Quercetin was used to make a 
calibration curve. In vivo test was used TBARS method carried out by measured 
malondialdehyde (MDA) level in male Wistar rats induced by paracetamol 2g/Kg 
BW. The test was carried out on extracts with doses of 125, 250, and 500 mg/Kg 
BW. Vitamin C with dose 6,5mg/Kg BW used as a positive control, and 1% of 
Na CMC used as the negative control. Histopathology assessment of liver used 
Hema-toxylin Eosin Stain. 
Results: Ethanolic extract of Chromolaena odorata L. leaves contain flavonoid 
126.459±0.163 mg/g extract as quercetin equivalent. Intoxication paracetamol 
on rats increased MDA serum level significantly different (p-value < 0.005) with 
normal control. Treatment of ascorbic acid and extracts decreased MDA serum 
level significantly different (p-value < 0.005) with control negative and improved 
the histological structure of hepatocytes.  
Conclusion: Ethanolic extract of Chromolaena odorata Linn. dose 500 mg/Kg 
BW was the best treatment with exhibited 58.974% reduction of MDA serum 
level and better improve the histological structure hepatocytes than other doses. 
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Degenerative diseases, such as diabetes, cardiovascular 
diseases, inflammation, cancer, aging, neurodegenerative 
diseases, and immunosuppression, are developed from 
the excess free radical molecules1,2. The primary role of 
free radical molecules causes of these diseases is related 
to lipid peroxidation3. Free radical molecules are formed 
by standard metabolic action and have been reported to 
be formed by radiation, bacterial and viral toxin, smoking, 
alcohol, and psychological or emotional stress4.  
 
Antioxidant compounds from medicinal plants play an es-
sential role in slowing or preventing free radical molecules' 
oxidation. Phenolic compounds, alkaloids, organic sulfur 
compounds, α-tocopherol, and β-carotene are phytochem-
ical compounds reported with antioxidant properties5. 
Chromolaena odorata Linn. is one of the tropical plants 
used as traditional medicines for diabetes in Indonesia's 
regions. Most of the Chromolaena genus contains the fla-
vonoids group. The previous study had reported that about 
40 flavonoids had been identified from the Chromolaena 
genus and some of these flavonoid groups have strong 
antioxidant properties6,7.  
 
In vitro, antioxidant activities of Chromolaena odorata L. 
leaves have been reported widely. Ethanolic extract of 
Chromolaena odorata L. leaves with concentration 
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300µg/mL has 59,89±0,002% DPPH scavenging activity8. 
Ethanolic extract of Chromolaena odorata L. contains 
7,39±0,40g chlorogenic acid in 100g of dry leaves showed 
the DPPH radical scavenging activity with IC50 of 
72,23µg/mL and 35,61% antioxidant activity of β-Carotene 
bleaching9. Methanolic extract of Chromolaena odorata L. 
leaf has IC50 scavenging of DPPH radical at 82,18µg/mL10. 
Ethanolic extract of Chromolaena odorata L. leaves has 
the highest DPPH radical scavenging activity than n-hex-
ane and ethyl acetate extract11.  
 
In vivo study using the TBARS method reported that etha-
nolic extract of Chromolaena odorata L. leaf has lower lipid 
peroxidation at 20mg/Kg BW compared with the control 
group. However, this value was not significantly different 
(p>0,05) statistically12. However, antioxidant in vivo stud-
ies use the TBARS method with dose variations that have 
not been reported. Currently, this research aims to evalu-
ate the antioxidant activity with various doses of ethanolic 
extract of Chromolaena odorata L. leaves against male 
Wistar rats induced by paracetamol. 
METHOD 
Study Design 
This is a true-experimental randomized pretest-posttest 
controlled trial. 
Study Site 
Pharmacological and Biological Pharmacy laboratories, 
Faculty of Mathematics and Natural Sciences, Sriwijaya 
University. Dyatnitalis anatomical pathology laboratory, 
Palembang 
Materials 
The dried leaves of Chromolaena odorata Linn., ethanol, 
aqua dest, methanol, Quercetin (Sigma-Aldrich®), Sodium 
acetate, AlCl3, aquabidest, Paracetamol standard (Dexa 
Medica), thiobarbituric acid (TBA) (Sigma-Aldrich®), tri-
chloro acetate (TCA) (Sigma-Aldrich®), tetra-ethoxy-pro-
pane (TEP) (Sigma-Aldrich®), Na CMC, Ascorbic acid 
standard (Dexa Medica Pharm. Industry). Hematoxylin Eo-
sin stain, Buffered formalin, Paraffin wax. 
Plant Extraction 
The dried leaves of Chromolaena odorata Linn. obtained 
from Belitung, South Sumatera, Indonesia. The 2 Kg of 
dried leaves were ground into powdered form then soak 
with ethanol 96% (1:10). The maceration process was kept 
in the amber bottle at room temperature for 72 hours and 
shaken occasionally. The macerate filtered then evapo-
rated with a rotary evaporator at 60°C until getting a thick 
extract. 
Total Flavonoid Content Assay 
Total flavonoid content was measured spectrophotometri-
cally based on the formation of complex flavonoid-alumin-
ium13. Quercetin was used to make a calibration curve. 
Quercetin was prepared by concentration 5, 10, 15, 20, 
and 25 µg/mL in methanol solution. The extract was pre-
pared by concentration 1000 µg/mL in methanol solution. 
One milliliter of sample solution was added with 1 mL of 
AlCl3 10% solution and 1 mL of sodium acetate 5%. The 
sample solution was incubated for 30 minutes, then meas-
ured absorbance value at λ 438 nm. The total flavonoid 
content was expressed as quercetin equivalents in mg/g 
(QE mg/g) extract. 
In Vivo Procedure 
Animal Preparation 
Male Wistar rats (150-200 g) were used in this study, and 
seventh days were acclimated at the laboratory facility. All 
animals were maintained with approved animal care oper-
ating procedures consistently. 
Experimental procedure 
In vivo, the antioxidant assay was measured with the thio-
barbituric acid reactive substance (TBARS) method14. The 
rats were divided into six groups, each comprising six rats. 
Group 1 (normal control) had free access to food. Group 2 
(Negative control) received 2 g/Kg BW of paracetamol sus-
pension once a day for six days, orally. Group 3 (Positive 
control) received 6.5 mg/Kg BW of ascorbic acid solution 
(in aquabidest) once a day six days later after receiving 
the same treatment of negative control. Group 4-6 (extract 
treatment) were received 125, 250, and 500 mg/Kg BW, 
respectively, once a day for six days later after received 
the same treatment of negative control. Blood serum was 
collected on the seventh and 14th day at sinus orbitalis. 
The MDA serum levels were obtained spectrophotometri-
cally at 532 nm. Percent reduction of MDA level calculated 
with equation (1). 
Percent reduction MDA level (%) =
MDA before treatment−MDA after treatment
MDA before treatment
𝑥 100 %   (1) 
Histopathology of Liver 
The histopathological assessment used the Hematoxylin 
Eosin stain as described before15. Liver tissues in each 
group were collected in 10% neutral buffered formalin. 
These tissues were processed and embedded in paraffin 
wax. Sections were cut used microtome with 5µm of thick-
ness and stained with hematoxylin and eosin (H&E). The 
sections were examined microscopically for the evaluation 
of histopathological changes. 
Statistical Analysis 
Results are expressed as mean ± standard deviation and 
analyzed using one-way ANOVA followed by Tukey's 
posthoc test and paired student T-test for serum MDA level 
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before and after treatment. The p values were two-tailed, 
and p < 0.05 was regarded as significant. Histopathologi-
cal data were analyzed descriptively. 
Ethical Consideration 
The Health Research Review Committee approved this 
study of Mohammad Hoesin Central General Hospital and 
Faculty of Medicine Sriwijaya University 
(182/kepkrsmhfkunsri/2019). 
RESULTS  
Plant Extraction and Total Flavonoid 
Measurement 
Chromolaena odorata L. leaves were extracted with 96% 
ethanol to produce a 321.79 g viscous extract. The extract 
yield was 16.08% of the dry weight. Measurement of the 
total flavonoid levels of the extract used a quercetin cali-
bration curve. Calibration curve equation obtained y = 
0.0188x - 0.0057 with a value of R² = 0.9998. The querce-
tin calibration curve is shown in Figure 1. Based on this 
equation, the total flavonoid of ethanolic extract of Chro-
molaena odorata L. leaves express as quercetin equiva-
lent was 126.459±0.163 mg/g. 
 
 
Figure 1. Quercetin Calibration Curve 
In Vivo Test 
Figure 2 shows that the negative, positive, and extract 
groups have been increased MDA levels after being intox-
icated by 2g/Kg BW of paracetamol once a day for six 
days. In contrast, the standard/normal control group was 
not induced by paracetamol as a reference for normal 
MDA levels. ANOVA analysis shows significantly different 
(p-value < 0.05) in the MDA level of each group. Based on 
Tukey's posthoc analysis, there is known that negative 
control, positive control, and 500mg/Kg BW extract groups 
have a significantly different value (p-value < 0.05) of MDA 
levels with the normal control group. However, the MDA 
level on all group treatment had no significant difference 
(p-value > 0.05) with the negative control. It is indicated 
that paracetamol has been increased the MDA serum level 
of rats. 
 
After the rats were treated for seven days, each group 
show a decrease in MDA levels, except for the normal and 
negative control groups. Figure 3 shows that the positive 
control group and each extract group have significantly dif-
ferent (p-value < 0,05) MDA levels from the negative con-
trol group. Table 1 shows the percent reduction value of 
MDA level after treatment. 
 

































BW of extract 
2.729±0.899 1.120±0.318* 
58.974 
(* = significantly different (p-value <0.05) of MDA before and after 
treatment with paired student T-test analysis) 
 
A paired student T-test had used to analyze the differ-
ences of MDA level after paracetamol intoxication and 
MDA level after treatment. Table 1 found that a positive 
group and extract groups significantly reduce MDA level 
after treatment (p-value < 0.05). Positive control has the 
highest reduction of MDA level compared to other treat-
ment groups. While in extract groups, 500 mg/Kg BW of 
ethanolic extract of Chromolaena odorata L. leaves was 
the best dose of an extract with 58.974% reduction of MDA 
level. Based on Tukey's posthoc analysis, all extract 
groups treatment had no significant difference (p-value > 
0.05) in MDA level with the positive control group. It can 
be concluded that the ethanolic extract of Chromolaena 
odorata L. leaves has the same effectiveness as ascorbic 
acid. 
Histopathology of Liver 
There are differences in hepatocyte structure in the para-
cetamol-induced group of rats compared to the normal 
control. Paracetamol induction causes inflammation and 
necrosis of the hepatocyte cells (Figure 4)15. 
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Figure 2. Serum MDA Level After Paracetamol Intoxication  
(* = significantly different with normal control (p-value < 0.05)) 
Figure 3. Serum MDA Level After Treatment 
(* = significantly different with negative control (p-value < 0.001)) 
 
    
    
   
 
Figure 4. Photograph of rat liver section shows A). Normal control shows the normal histological structure of 
hepatocyte (H) and sinusoid (S), B). Negative control shows more inflammatory infiltration, necrosis (arrow), and 
binucleated cell (BN) of hepatocyte, C). Positive control shows less necrosis (arrow) and binucleated cell (BN) of 
hepatocyte, D). Extract dose I shows inflammatory infiltration, necrosis (arrow), pyknotic nuclei (PK), and binucleated 
cells (BN) of hepatocyte, E). Extract dose II shows necrosis (arrow), pyknotic nuclei (PK), and binucleated cells (BN) 
of hepatocyte, F). Extract dose III shows necrosis (arrow), pyknotic nuclei (PK), and binucleated cells (BN) of the 
hepatocyte. (1) magnification 40x, (2) magnification 400x 
 
DISCUSSION 
Chromolaena odorata Linn. is a member of the family Eu-
patoriae (Asteraceae)7. In Belitung, South Sumatera re-
gion, Indonesia, Chromolaena odorata Linn is known as 
"merdekaan," a popular folk medicine for diabetes treat-
ment. Ethanolic extract of Chromolaena odorata Linn. 
leaves contain flavonoids, alkaloids, tannins, phenolics, 
saponins, steroids, and triterpenoids (data not shown). 
Some phenolic group compounds have been found in 
Chromolaena odorata L. leaf; there are p-coumaric acid, 
p-hydroxybenzoic acid, protocatechuic acid, ferulic acid, 
vanillic acid16. Odoratenin, isosakuranetin, and subscan-
denin, a new flavanone compound, in Chromolaena odo-
rata L.leaf was found by Putri6. High phenolic content is 
beneficial as the phenolic compound quench primary oxi-
dants or free radicals17. Balamurugan9 was investigated 
that indirect ethanolic extraction of Chromolaena odorata 
L. leaves has the highest total phenolic compound and to-
tal antioxidant content compare to other solvents in se-
quential extraction. Ethanol is a useful solvent to extract 
phenolic and flavonoid compounds and is safe for human 
consumption18. Flavonoid and phenolic compounds have 
free radical scavenging activity by donating their free elec-
tron pairs to radical molecules9. This study was measured 
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the total flavonoid of ethanolic extract of Chromolaena 
odorata L. leaves; it has 126.459±0.163 mg QE/g extract.   
 
Chromolaena odorata L. leaves have been shown as a po-
tent antioxidant in various in vitro assays 8–11,13,16,19–24. 
However, in vivo assays of antioxidant activity of this plant 
are limited. Uhegbu12 was investigating the activity of 
Chromolaena odorata L., Ageratum conyzoides L, and 
their combination to reduce lipid peroxidation in rats. The 
evaluation shows that ethanolic extract of Chromolaena 
odorata L. leaf has lower lipid peroxidation (TBARS) at 
20mg/Kg BW than the control group. However, this value 
was not significantly different (p-value > 0.005) statisti-
cally. To our knowledge, in vivo study with various doses 
of Chromolaena odorata L. leaves has not been evaluated. 
This study was aimed to evaluate the antioxidant activity 
in system organisms used various doses of the extract. We 
used Wistar strain male rats as the test animal. The study 
used six groups: normal control, negative control, positive 
control, 125 mg/Kg BW, 250 mg/Kg BW, and 500 mg/Kg 
BW of ethanolic extract Chromolaena odorata Linn. 
leaves. Except for normal control, the five groups received 
2mg/Kg BW of Paracetamol once a day for six days to el-
evate the MDA serum level.  
 
Paracetamol with toxic dose can significantly elevate 
Malone dialdehyde (MDA) level serum of rats. The eleva-
tion of Malone dialdehyde (MDA) level serum indicates of 
increase in lipid peroxidation25. Paracetamol had reported 
disturbing the balance between free radical molecules pro-
duction and antioxidant protection, especially in the liver. 
N-acetyl-p-benzoquinone imine (NAPQI) formation by cy-
tochrome P450 (CYP), a highly reactive toxic electrophile, 
is a toxic compound produced by paracetamol. When the 
rate of NAPQI formation exceeds the detoxification rate by 
glutathione, it is oxidized tissue macromolecules such as 
lipid or -SH group of proteins. Lipid peroxidation is an au-
tocatalytic process, which is a common consequence of 
cell death26. MDA is one of the end products in the lipid 
peroxidation process. The increased MDA content might 
have resulted from an increase of free radical molecules 
due to stress due to Paracetamol intoxication27.  
 
Serum MDA level of negative control, positive control, 125 
mg/Kg BW, 250 mg/Kg BW, and 500 mg/Kg BW of etha-
nolic extract of Chromolaena odorata Linn. leaves after pa-
racetamol intoxication has significantly higher (p-value < 
0.05) than normal control (Figure 2). The reduction of MDA 
level serum in the positive control group, 125 mg/Kg BW, 
250 mg/Kg BW, and 500 mg/Kg BW of ethanolic extract of 
Chromolaena odorata Linn. leaves have significantly dif-
ferent (p-value < 0.05) with negative control (Figure 3). 
Ascorbic acid in the positive control group has the highest 
percent reduction in MDA level (68.146%). Besides that, 
500mg/Kg BW of ethanolic extract has a 58.974% reduc-
tion of MDA level, higher than other doses.  Ascorbic acid 
as a standard drug, flavonoid, and phenolic compound in 
the extract has antioxidant activity that inhibits the enzyme 
involved in free radical molecules formation28. Peluso29 
has been reported that flavonoids could interfere with 
drugs’ bioavailability through competition with cytochrome 
P450 (CYP) enzymes. So, the metabolism of paracetamol 
into NAPQI form can be reduced. 
 
Figure 4, A1-A2 liver sections of the normal control group 
showed the typical histological structure of hepatocytes 
with well-preserved cytoplasm and well-defined nucleus. 
The negative control group (Figure 4, B1-B2) showed dis-
arrangement of normal hepatocytes, necrosis of cells, and 
inflammatory infiltration. There were binucleated cells and 
less necrosis of hepatocytes (Figure 4, C1-C2). Apart from 
necrosis of cells and binucleated cells, pyknotic nuclei 
were also found in extract treatment groups (Figure 4, D-
F1-2). In our present study, there were histopathological 
changes in response to paracetamol. Indication of marked 
changes in the liver's overall histoarchitecture could be 
due to its toxic effects by the generation of radical mole-
cules that damage the various membrane components of 
the cell—the necrotic condition in rats mostly character-
ized by pyknosis cytoplasm30. The formation of highly re-
active radicals because of paracetamol intoxication can 
cause liver function failure31. Lipid peroxidation can disturb 
cellular membranes' integrity, leading to the leakage of cy-
toplasmic enzymes due to severe histopathological dam-
ages32,33. The phenolic compound, such as quercetin, was 
proven to possess hepatoprotective effect in an animal test 
against liver damage induced by lipid peroxidation34. Phe-
nolic compounds prevent paracetamol-induced lipid pe-
roxidation was due to antioxidant activities. Chromolaena 
odorata L. leaves have strong antioxidant properties and 
inhibit lipid peroxidation due to hepatoprotective effect in 
rats against liver damage induced by paracetamol. 
CONCLUSIONS AND RECOMMENDATION 
This study concludes that ethanolic extract of Chromo-
laena odorata Linn. leaves contain a flavonoid of 
126.459±0.163 mg QE/g extract. Extract with a 500 mg/Kg 
BW dose was the best treatment with exhibited 58.974% 
reduction of MDA serum level. Ascorbic acid and all extract 
treatments showed improvement in the histological struc-
ture of hepatocytes. Therefore, the next study should be 
directed toward using extract rich flavonoids to reduce 
doses and increase the activity. The small extract dosage 
will be more acceptable to make dosage preparations for 
human usage. 
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